Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1N acetyl cysteine[1] Cysteine[2] D00026 ,
D02326 		--[2] 6, 19
2N Acetyl L Leucine[1] Leucine[1] D00030 --[1] 19
3N acetylcysteine[1] Acetylcysteine[1] D00221 --[1] 13
4N(4,5Bis methanesulfonyl2methylbenzoyl) guanidine hydrochloride monohydrate[1] Guanidine[1] D02437 --[1] 113
5N,N,N',N'-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)[1] Phenothiazine[1] D02601 --[1] 127
6N,N,N?,N?-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)[1] Phenothiazine[1] D02601 --[1] 127
7N,N,N’,N’-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)[1] Phenothiazine[1] D02601 --[1] 127
8N-(4,5-Bis methanesulfonyl-2-methyl-benzoyl)guanidine hydrochloride monohydrate[1] Guanidine[1] D02437 --[1] 113
9N-(5-hydroxy-2,4- bis(trimethylsilyl)phenyl)-4-oxo- 1,4-dihydroquinoline-3-carboxamide----[1] 299
10N-(5-hydroxy-2,4-bis(trimethylsilyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide----[1] 299
11N-(5-{4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide----[1] 49
12N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide----[1] 299
13N-0923----[1] 6
14N-3 LC-PUFA----[1] 46
15N-3 Polyunsaturated Fatty Acids----[1] 96
16N-[1-((5-cyanopyridin-2-yl)methyl)-1H-pyrazol-3-yl]-2-[4-(1-(trifluoromethyl)cyclopropyl)phenyl]acetamide[2] Acetamide,
Pyrazole		---[1] 154
17N-acetyl Cysteine[1] Cysteine[2] D00026 ,
D02326 		--[7] 13, 19, 34, 85, 88, 296, 310
18N-Acetyl Cysteine (NAC)[1] Cysteine[2] D00026 ,
D02326 		--[1] 90
19N-acetyl-cysteine[1] Cysteine[2] D00026 ,
D02326 		--[1] 84
20N-Acetyl-L Leucine[1] Leucine[1] D00030 --[1] 19
21N-Acetyl-L-Leucine[1] Leucine[1] D00030 --[2] 19, 65
22N-acetylcystein----[1] 299
23N-Acetylcysteine[1] Acetylcysteine[1] D00221 --[11] 6, 13, 19, 20, 49, 58, 85, 111, 164, 299, 337
24N-acetylcysteine (NAC)[1] Acetylcysteine[1] D00221 --[3] 34, 51, 299
25N-acetylcysteine capsule[1] Acetylcysteine[1] D00221 --[1] 6
26N-acetylcysteine syrup[1] Acetylcysteine[1] D00221 --[1] 53
27N-Acetylcysteine, (NAC)[1] Acetylcysteine[1] D00221 --[1] 85
28N-acetylgalactosamine 4-sulfatase----[1] 19
29N-acetylneuraminic acid----[1] 30
30N-Carbamylglutamate[1] Carglumic acid[1] D07130 [1] CPS1 💬[6] Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Biosynthesis of amino acids, Carbon metabolism, Metabolic pathways, Nitrogen metabolism 💬[2] 245, 246
31N-methyl D-(2,3,4,5,6-pentahydroxy-hexyl)-ammonium----[1] 28
32N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine----[1] 13
33N-trans-3-Hexenoyl] Human Growth Hormone Releasing Factor (1-44) Acetate[2] Acetate,
Somatotropin		[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 265
34N-{4-Chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamide, sodium----[1] 96
35N-{4-Chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamidesodium----[1] 96
36N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO----[1] 11
37N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 ADSORBED ON ALUMINUM HYDROXIDE[5] Aluminium,
Aluminum hydroxide,
Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein,
Hydroxide ion		[1] D02416 --[1] 11
38N. MENINGITIDIS GROUP C POLYSACCHARIDE----[1] 14
39N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197[1] Corynebacterium diphtheriae CRM197 protein---[1] 13
40N.a.----[10] 3, 6, 8, 13, 46, 96, 97, 240, 256, 271
41N.d.----[1] 97
42N02BG10----[1] 13
43N03AX12----[1] 13
44N04BA----[1] 6
45N04BC07----[1] 6
46N04BD02----[1] 6
47N06DX01----[1] 13
48N1,N3-BIS(2-MERCAPTOETHYL) ISOPHTHALAMIDE----[2] 5, 17
49N6022----[1] 299
50N91115----[1] 299
51Na----[3] 36, 46, 85
52Na18F----[1] 13
53NABILONE[1] Nabilone[1] D05099 [2] CNR1,
CNR2 💬		[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[2] 6, 13
54Nabilone 0.25 mg[1] Nabilone[1] D05099 [2] CNR1,
CNR2 💬		[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[1] 6
55Nabiximols[1] Nabiximols[1] D09317 --[1] 13
56Nabiximols - Sativex[2] Dronabinol,
Nabiximols		[2] D00306 ,
D09317 		[2] CNR1,
CNR2 💬		[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[1] 13
57NAC----[5] 34, 51, 85, 90, 299
58NAC effervescent tablets----[1] 90
59NaCl----[1] 227
60NaCl 0,9%----[1] 53
61NaCl 0.9%----[1] 39
62Nacom----[1] 6
63NACOM 100----[1] 6
64NACOM levodopa+cardidopa[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
65Nacystelyn----[1] 299
66Nacystelyn®----[1] 299
67NADH[1] NADH---[1] 302
68Nadolol[1] Nadolol[1] D00432 [2] ADRB1,
ADRB2 💬		[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
69Naglazyme[1] Galsulfase[1] D06565 [1] ARSB 💬[3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬[1] 19
70Naglazyme (galsulfase)[1] Galsulfase[1] D06565 [1] ARSB 💬[3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬[1] 19
71Naglazyme®[1] Galsulfase[1] D06565 [1] ARSB 💬[3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬[1] 19
72NAL----[2] 6, 299
73Nalbuphine[1] Nalbuphine[2] D00843 ,
D08246 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 85
74Nalbuphine ER[1] Nalbuphine[2] D00843 ,
D08246 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 85
75Nalbuphine Extended-Realease (ER) Tablets[1] Nalbuphine[2] D00843 ,
D08246 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 85
76Nalbuphine Extended-Release (ER) Tablets[1] Nalbuphine[2] D00843 ,
D08246 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 85
77NALBUPHINE HYDROCHLORIDE[1] Nalbuphine[2] D00843 ,
D08246 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 85
78Nalmefene[1] Nalmefene[1] D05111 [3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
79Naloxone[1] Naloxone[2] D01340 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[2] 6, 226
80NALOXONE HYDROCHLORIDE[1] Naloxone[2] D01340 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
81NALOXONE HYDROCHLORIDE DIHYDRATE[1] Naloxone[2] D01340 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
82Naltrexone[1] Naltrexone[2] D02095 ,
D05113 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[12] 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226
83NALTREXONE CLORIDRATO[1] Naltrexone[2] D02095 ,
D05113 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 10
84NALTREXONE HYDROCHLORIDE[1] Naltrexone[2] D02095 ,
D05113 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[8] 10, 40, 41, 42, 43, 44, 45, 96
85Naltrexone-HCl[1] Naltrexone[2] D02095 ,
D05113 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 96
86NAMILUMAB[1] Namilumab---[1] 46
87Namilumab (MT203)[1] Namilumab---[1] 46
88Namisol----[2] 13, 298
89Namuscla[1] Mexiletine[2] D00639 ,
D08215 		[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 114
90NAND (Neoandrographolide)----[1] 97
91Nandrolone[1] Nandrolone[1] D08250 [1] AR 💬[4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[2] 60, 85
92Nandrolone Decanoate[2] Nandrolone,
Nandrolone decanoate		[2] D00955 ,
D08250 		[1] AR 💬[4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[2] 60, 85
93Nanobubble drink----[1] 46
94Nanocort----[3] 13, 46, 97
95Nanocrystalline silver (Acticoat)[1] Silver---[2] 35, 162
96Nanocurcumin----[2] 13, 271
97Nanogam----[1] 63
98Nanogam 100 mg/ml----[1] 65
99Nanogam® 50 mg/ml----[1] 65
100Nanoparticulated Rebamipide[1] Rebamipide[1] D01121 --[1] 46
101Nanosuspension)----[1] 113
102Nap----[2] 96, 240
103NaPBA----[1] 251
104Naprosyn[1] Naproxen[1] D00118 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 271
105Naprosyn 500 mg[1] Naproxen[1] D00118 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46
106Naprosysn----[1] 271
107Naproxen[1] Naproxen[1] D00118 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[4] 13, 46, 107, 271
108Naproxen (EC-Narosyn) Delayed Release Tables, 375 (Syntex (USA), Inc.)[1] Naproxen[1] D00118 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46
109Naproxen 10 mg/kg[1] Naproxen[1] D00118 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46
110Naproxen 500 mg tablets (PN 200 minus omeprazole)[2] Naproxen,
Omeprazole		[5] D00118 ,
D00455 ,
D01207 ,
D05259 ,
D05261 		[4] ATP4A,
ATP4B,
PTGS1,
PTGS2 💬		[26] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[2] 46, 271
111Naproxen Delayed Release Tables, 375 (Gevena Pharmaceuticals, Inc.)[1] Naproxen[1] D00118 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46
112Naproxen oral suspension[1] Naproxen[1] D00118 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46
113NAPROXEN SODIUM[1] Naproxen[1] D00118 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 107
114Naproxen sodium 550mg tablet[1] Naproxen[1] D00118 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46
115Nardil[1] Phenelzine[2] D00505 ,
D08349 		[2] MAOA,
MAOB 💬		[14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[1] 6
116Narrow Band Imaging----[1] 97
117Narsoplimab[1] Narsoplimab[1] D11531 [1] MASP2 💬[3] Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬[2] 66, 222
118Nasal Aztreonam[1] Aztreonam[2] D00240 ,
D06558 		--[1] 299
119Nasonex----[1] 98
120Nasopharyngeal swabs----[1] 46
121NATALIZUMAB[1] Natalizumab[1] D06886 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[5] 13, 15, 25, 46, 96
122Natalizumab (BG00002)[1] Natalizumab[1] D06886 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
123Natalizumab (NTZ)[1] Natalizumab[1] D06886 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
124Natalizumab (Tysabri)[1] Natalizumab[1] D06886 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
125Natalizumab 300 MG in 15 ML Injection[1] Natalizumab[1] D06886 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
126Natalizumab for IV Infusion[1] Natalizumab[1] D06886 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
127Natalizumab for Subcutaneous Injection[1] Natalizumab[1] D06886 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
128Natalizumab Injection [Tysabri][1] Natalizumab[1] D06886 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
129Natalizumab IV[1] Natalizumab[1] D06886 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
130Natalizumab SC[1] Natalizumab[1] D06886 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
131Natalizumab treatment[1] Natalizumab[1] D06886 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
132National Drug Code: 59762-0074----[1] 81
133Natpar[1] Parathyroid hormone[1] D05364 [2] PTH1R,
PTH2R 💬		[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235
134Natpara----[1] 235
135NATPARA/NATPAR[1] Parathyroid hormone[1] D05364 [2] PTH1R,
PTH2R 💬		[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235
136Natriumchlorid[1] Sodium chloride[1] D02056 --[1] 288
137Natriumchlorid 0,9 %[1] Sodium chloride[1] D02056 --[1] 288
138Natriumklorid 9mg/ml----[1] 46
139Natriuretic peptide----[1] 276
140Navocaftor----[1] 299
141NBI-5788----[1] 13
142NBI-74788----[1] 81
143NBI-77860----[1] 81
144NBI-827104----[1] 154
145NBMI----[2] 5, 17
146NBT-NM108 (60 g/day)----[1] 13
147NBTX-001----[1] 6
148NC 1 cell therapy----[1] 117
149NC-503 (Anti-amyloidotic (AA) Agent)----[1] 46
150NCA 500mg----[1] 93
151Nd----[6] 2, 6, 13, 46, 51, 97
152ND-L02-s0201----[1] 85
153ND-L02-s0201 for injection----[1] 85
154ND0611----[1] 6
155ND0612----[1] 6
156ND0612 (Levodopa/Carbidopa solution)[2] Carbidopa,
Levodopa		[2] D00059 ,
D00558 		[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
157ND1421----[1] 6
158ND1587----[1] 6
159ND1589----[1] 6
160ND1590----[1] 6
161ND1702----[1] 6
162NDC0009-0436-01----[1] 78
163NDV-3A----[1] 65
164NE3107----[1] 6
165Near-infrared-induced autofluorescence and indocyanine green near-infrared angiography[1] Indocyanine green[1] D01342 --[1] 235
166NEB/01-07----[1] 299
167Nebcin----[1] 299
168Nebcin (tobramycin)[1] Tobramycin[2] D00063 ,
D02542 		--[1] 299
169Nebcinal----[1] 299
170Nebcinal Tobi----[1] 299
171NEBCINE----[1] 299
172Nebicapone[1] Nebicapone---[1] 6
173Nebido----[1] 13
174Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection[2] Testosterone,
Testosterone undecanoate		[6] D00075 ,
D00957 ,
D00958 ,
D00959 ,
D06085 ,
D06087 		[1] AR 💬[4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[1] 13
175Nebivolol[1] Nebivolol[1] D05127 [1] ADRB1 💬[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 17, 85, 113, 167
176Nebivolol 5 mg[1] Nebivolol[1] D05127 [1] ADRB1 💬[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 17
177Nebulization of Amikacin during NIV (RR: 15 cycles/minute)[1] Amikacin[2] D00865 ,
D02543 		--[1] 299
178Nebulization of Amikacin during NIV (RR: 25 cycles/minute)[1] Amikacin[2] D00865 ,
D02543 		--[1] 299
179Nebulization tobramycin[1] Tobramycin[2] D00063 ,
D02542 		--[1] 299
180Nebulized combination ipratropium bromide with salbutamol[2] Ipratropium,
Salbutamol		[2] D02147 ,
D02212 		[6] ADRB2,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		[18] Adrenergic signaling in cardiomyocytes, Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86
181Nebulized ipratropium bromide[1] Ipratropium[1] D02212 [5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		[13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 86
182Nebulizer----[1] 6
183Necator americanus----[1] 13
184Nedosiran----[1] 234
185Needle biopsy of the vastus lateralis muscle----[1] 113
186NEFECON----[1] 66
187Neflamapimod[1] Neflamapimod[1] D10959 [4] MAPK11,
MAPK12,
MAPK13,
MAPK14 💬		[62] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬[1] 8
188NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED WITH TETANUS TOXOID CARRIER PROTEIN[1] Clostridium tetani toxoid antigen (formaldehyde inactivated)---[1] 50
189NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETA[1] Triethylenetetramine---[1] 50
190NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN[1] Clostridium tetani toxoid antigen (formaldehyde inactivated)---[1] 50
191Nelfinavir[1] Nelfinavir[2] D00899 ,
D08259 		--[3] 49, 265, 331
192Nelfinavir mesylate[1] Nelfinavir[2] D00899 ,
D08259 		--[1] 265
193Nelotanserin[1] Nelotanserin[1] D09645 [1] HTR2A 💬[5] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬[1] 6
194Nelutri™----[1] 84
195Nemolizumab[1] Nemolizumab[1] D11080 [1] IL31RA 💬[1] Cytokine-cytokine receptor interaction 💬[1] 51
196Neo-ASA----[1] 251
197NEO-GAA----[1] 256
198Neo-Recormon----[1] 18
199NEOD001----[1] 28
200NeoFuse----[1] 70
201NeoGAA[1] Avalglucosidase alfa[1] D11744 [1] GAA 💬[4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬[1] 256
202NeoGAA or avalglucosidase alfa[1] Avalglucosidase alfa[1] D11744 [1] GAA 💬[4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬[1] 256
203Neomycin[1] Neomycin[1] D08260 --[3] 96, 97, 296
204Neophyr 1000ppm mol/mol----[1] 294
205Neopterin[1] Neopterin---[1] 65
206Neoral[1] Cyclosporine[1] D00184 [5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[3] 60, 97, 222
207Neoral Oral Solution[1] Cyclosporine[1] D00184 [5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 269
208Neoral Soft Gelatin Capsules[2] Cyclosporine,
Gelatin		[3] D00115 ,
D00184 ,
D06892 		[5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[2] 97, 269
209NeoRecormon----[2] 13, 18
210Neostigmine[1] Neostigmine[1] D08261 [1] ACHE 💬[2] Cholinergic synapse, Glycerophospholipid metabolism 💬[1] 11
211Neovasculgen----[1] 51
212Neramexane[1] Neramexane---[1] 13
213Neramexane mesylate[1] Neramexane---[1] 13
214Neridronic Acid[1] Neridronic Acid---[1] 6
215Nerispirdine[1] Nerispirdine---[1] 13
216Nerispirdine (HP184)[1] Nerispirdine---[1] 13
217Nerispirdine hydrochloride[1] Nerispirdine---[1] 13
218NERIXIA*IM EV 1F 25MG----[1] 6
219NERIXIA*INFUS IV CONC 2F 100MG----[1] 274
220Nerve block----[1] 46
221Nerve Growt Factor - 2.5S----[1] 90
222Nerve Growth Factor[1] Nerve Growth Factor---[3] 3, 53, 90
223Nessuno----[1] 96
224Nested PCR for formalin-fixed tissues[1] Formaldehyde[1] D00017 --[1] 84
225Nested PCR for fresh tissues----[1] 84
226Neu-120----[1] 6
227Neumega (Oprelvekin, Interleukin 11, IL-11)[1] Oprelvekin[1] D05266 [1] IL11RA 💬[3] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬[1] 288
228NEUPOGEN----[4] 13, 28, 51, 285
229NEUPRO[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
230Neupro (Reference)[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
231NEUPRO 2 mg/24 h parche transdérmico[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
232Neupro 2 mg/24 h transdermal patch[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
233Neupro 2mg/24 h transdermal patch[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
234Neupro 2mg/24h transdermal patch[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
235NEUPRO 4 mg/24 h parche transdérmico[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
236Neupro 4 mg/24 h transdermal patch[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
237Neupro 4mg/24 h transdermal patch[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
238Neupro 4mg/24h transdermal patch[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
239Neupro 4Mg/24Hr Transdermal Patch[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
240NEUPRO 6 mg/24 h parche transdérmico[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
241Neupro 6 mg/24 h transdermal patch[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
242Neupro 6mg/24 h transdermal patch[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
243Neupro 6mg/24h transdermal patch[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
244NEUPRO 8 mg/24 h parche transdérmico[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
245Neupro 8 mg/24 h transdermal patch[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
246Neupro 8mg/24h transdermal patch[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
247NEUPRO*28CER 2MG/24H[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
248NEUPRO*28CER 4MG/24H[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
249NEUPRO*28CER 6MG/24H[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
250NEUPRO*28CER 8MG/24H[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
251NEUPRO*7CER 4MG/24H[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
252NEUPRO*7CER 6MG/24H[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
253NEUPRO*7CER 8MG/24H[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
254Neupro®[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
255Neupro® 8 mg/24 h[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
256Neuraceq[1] Florbetaben (18F)---[1] 6
257NEUROASPIS PLP10®----[1] 13
258NEUROBLOC[1] Botulinum toxin type B[1] D02735 [1] SNAP25 💬[2] Insulin secretion, Synaptic vesicle cycle 💬[1] 6
259NeuroEPO----[1] 6
260Neurohormonal mechanisms----[2] 6, 127
261Neurological evaluation----[1] 25
262Neurology examination----[1] 78
263Neuromuscular electrical stimulation delivered using the electrical therapy device EMPI 300 PV----[1] 13
264NEURONTIN[1] Gabapentin[1] D00332 [5] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬		[9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬[1] 13
265Neurontin 300 mg hard capsule[1] Gabapentin[1] D00332 [5] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬		[9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬[1] 13
266Neuropsychological Testing----[1] 78
267NeuroVax----[1] 13
268NeuroVax 300ug/mL Dose for IM Injection----[1] 13
269Neurpro----[1] 6
270Nevanimibe[1] Nevanimibe[1] D11300 --[2] 75, 81
271Nevanimibe hydrochloride[1] Nevanimibe[1] D11300 --[2] 75, 81
272Nevirapine[1] Nevirapine[1] D00435 --[1] 265
273New formulation adalimumab[1] Adalimumab[1] D02597 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46
274New Formulation Etanercept[1] Etanercept[1] D00742 [2] LTA,
TNF 💬		[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46
275New Formulation of rebif - human interferon beta-1a[2] Human interferon beta,
Interferon beta-1a		[1] D04554 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
276New thermo stable formulation of epoprostenol sodium[1] Epoprostenol[2] D00106 ,
D01337 		[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
277NewGam----[3] 14, 63, 65
278Newnorm----[1] 65
279Nexavar[1] Sorafenib[2] D06272 ,
D08524 		[8] BRAF,
FLT3,
FLT4,
KDR,
KIT,
PDGFRB,
RAF1,
RET 💬		[89] Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬[1] 34
280Nexavar (BAY 43-9006) (Sorafenib)[1] Sorafenib[2] D06272 ,
D08524 		[8] BRAF,
FLT3,
FLT4,
KDR,
KIT,
PDGFRB,
RAF1,
RET 💬		[89] Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬[1] 34
281Nexium[1] Esomeprazole[4] D01984 ,
D04056 ,
D07917 ,
D09339 		[2] ATP4A,
ATP4B 💬		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[1] 299
282Nexium (esomeprazole magnesium)[2] Esomeprazole,
Magnesium		[4] D01984 ,
D04056 ,
D07917 ,
D09339 		[2] ATP4A,
ATP4B 💬		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[1] 298
283Nexium 20[1] Esomeprazole[4] D01984 ,
D04056 ,
D07917 ,
D09339 		[2] ATP4A,
ATP4B 💬		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[1] 299
284NFC-1----[1] 203
285NFX-179 Gel----[1] 34
286NG-Monomethyl-L-arginine[2] Arginine,
Tilarginine		[1] D02982 --[1] 67
287Ng-monomethyl-L-arginine (drug)[2] Arginine,
Tilarginine		[1] D02982 --[1] 67
288NGM282----[2] 93, 94
289NGX267[1] NGX267---[1] 53
290NI-0101----[1] 46
291NI-03----[1] 298
292NI-0401 (anti-CD3 mAB)[1] Muromonab[1] D05092 [3] CD3D,
CD3E,
CD3G 💬		[11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[1] 96
293NI-0501----[1] 107
294NI-071----[1] 46
295NI-0801----[1] 93
296Niacin[1] Niacin[1] D00049 --[3] 6, 78, 265
297Niacin First[1] Niacin[1] D00049 --[1] 78
298Niacinamide[1] Nicotinamide[1] D00036 --[4] 5, 6, 13, 67
299Nicardipine[1] Nicardipine[2] D00617 ,
D08270 		[4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 70, 86
300Niclosamide[1] Niclosamide[1] D00436 --[2] 46, 97
301Nicolon----[1] 97
302Nicorette 10mg/ 16 h[1] Nicotine[3] D03365 ,
D05156 ,
D05157 		[16] CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		[7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬[1] 6
303Nicorette 15 mg/ 16 h[1] Nicotine[3] D03365 ,
D05156 ,
D05157 		[16] CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		[7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬[1] 6
304Nicorette 5 mg/ 16 h[1] Nicotine[3] D03365 ,
D05156 ,
D05157 		[16] CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		[7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬[1] 6
305Nicotinamide[1] Nicotinamide[1] D00036 --[8] 2, 6, 18, 49, 65, 107, 162, 191
306Nicotinamide ribonucleoside[1] Nicotinamide[1] D00036 --[1] 65
307Nicotinamide riboside[2] Nicotinamide,
Nicotinamide riboside		[1] D00036 --[4] 2, 6, 18, 191
308NICOTINE[1] Nicotine[3] D03365 ,
D05156 ,
D05157 		[16] CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		[7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬[3] 6, 13, 84
309Nicotine gum[1] Nicotine[3] D03365 ,
D05156 ,
D05157 		[16] CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		[7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬[1] 6
310Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY)[1] Nicotine[3] D03365 ,
D05156 ,
D05157 		[16] CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		[7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬[1] 6
311Nicotine patch[1] Nicotine[3] D03365 ,
D05156 ,
D05157 		[16] CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		[7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬[2] 6, 84
312Nicotine transdermal patch[1] Nicotine[3] D03365 ,
D05156 ,
D05157 		[16] CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		[7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬[1] 6
313Nicotinell----[1] 6
314Nicotinell 17,5 mg/24-Stunden-Pflaster----[1] 6
315Nicotinell 35 mg/24-Stunden-Pflaster----[1] 6
316Nicotinic acid[1] Niacin[1] D00049 --[1] 79
317Nifedipine[1] Nifedipine[1] D00437 [4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 50, 81
318Nifurtimox[1] Nifurtimox[1] D00833 --[1] 65
319Nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7d[2] Eflornithine,
Nifurtimox		[2] D00833 ,
D07883 		[1] ODC1 💬[3] Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬[1] 65
320Nifurtimox-Eflronithine Combination Treatment (NECT)[1] Nifurtimox[1] D00833 --[1] 65
321Nilotinib[1] Nilotinib[1] D08953 [4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬		[33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[5] 6, 8, 34, 51, 86
322Nilotinib (Tasigna)[1] Nilotinib[1] D08953 [4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬		[33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 51
323Nilotinib 150 MG[1] Nilotinib[1] D08953 [4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬		[33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 8
324Nilotinib 150mg oral capsule [Tasigna][1] Nilotinib[1] D08953 [4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬		[33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 6
325Nilotinib 300mg oral capsule [Tasigna][1] Nilotinib[1] D08953 [4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬		[33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 6
326Nilotinib 50 mg[1] Nilotinib[1] D08953 [4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬		[33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 86
327NILOTINIB HYDROCHLORIDE MONOHYDRATE[1] Nilotinib[1] D08953 [4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬		[33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 34
328Nilvadipine[1] Nilvadipine[1] D01908 [4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 90
329Nimenrix[1] Clostridium tetani toxoid antigen (formaldehyde inactivated)---[2] 50, 61
330Nimesulide[1] Nimesulide[1] D01049 [1] PTGS2 💬[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46
331Ninlaro[1] Ixazomib[1] D10130 [1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[2] 13, 61
332NINTEDANIB[1] Nintedanib[1] D10481 [8] FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬		[34] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬[5] 51, 85, 89, 227, 228
333Nintedanib 150 mg and 100 mg soft capsules[1] Nintedanib[1] D10481 [8] FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬		[34] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬[1] 227
334Nintendo Wii Fit Balance Board[1] Isoxaflutole---[1] 13
335Nintédanib----[1] 227
336NIOX MINO® Airway Inflammation Monitor[1] Methamidophos---[1] 98
337NIP292 tablet----[1] 85
338NIP292 tablets----[1] 85
339Nipocalimab[1] Nipocalimab[1] D11666 [1] FCGRT 💬-[5] 11, 46, 49, 53, 61
340NIRS after bosentan administration[1] Bosentan[2] D01227 ,
D07538 		[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13
341NIRS baseline----[1] 13
342Nitazoxanide[1] Nitazoxanide[1] D02486 --[2] 96, 97
343Nitazoxanide 500Mg Oral Tablet[1] Nitazoxanide[1] D02486 --[1] 97
344NITISINONE[1] Nitisinone[1] D05177 [1] HPD 💬[5] Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬[3] 6, 164, 241
345Nitisinone 10 mg Tablet High Compritol[1] Nitisinone[1] D05177 [1] HPD 💬[5] Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬[1] 241
346Nitisinone Baked Tablet[1] Nitisinone[1] D05177 [1] HPD 💬[5] Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬[1] 241
347Nitrate[1] Nitrate[1] D02313 --[3] 58, 113, 299
348Nitric Oxide[1] Nitric Oxide[1] D00074 --[8] 46, 85, 86, 98, 210, 251, 294, 299
349Nitric Oxide 160 ppm[1] Nitric Oxide[1] D00074 --[1] 299
350Nitric Oxide for inhalation[1] Nitric Oxide[1] D00074 --[2] 86, 299
351Nitric Oxide generated by the GeNO nitrosyl delivery system[1] Nitric Oxide[1] D00074 --[1] 86
352Nitric Oxide plus Oxygen[2] Nitric Oxide,
Oxygen		[2] D00003 ,
D00074 		--[1] 86
353Nitric oxide supplement[1] Nitric Oxide[1] D00074 --[1] 251
354Nitrite[1] Nitrite---[3] 58, 86, 299
355Nitrofurantoin[1] Nitrofurantoin[1] D00439 --[1] 13
356Nitrogen[1] Nitrogen[1] D00083 --[6] 5, 6, 17, 171, 211, 299
357Nitroglycerin[1] Nitroglycerin[1] D00515 --[1] 51
358Nitroglycerin Ointment 2%[1] Nitroglycerin[1] D00515 --[1] 51
359Nitroglycerine[1] Nitroglycerin[1] D00515 --[2] 46, 51
360Nitroglycerine gel[1] Nitroglycerin[1] D00515 --[1] 51
361Nitroprusside[1] Nitroprusside[1] D00614 --[1] 51
362Nitrosyl[1] Nitric Oxide[1] D00074 --[1] 86
363Nitrous Oxide[1] Nitrous oxide[1] D00102 --[1] 34
364NiuBangZi pill----[1] 46
365Nivolumab[1] Nivolumab[1] D10316 [1] PDCD1 💬[3] Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬[12] 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159
366NIZORAL[1] Ketoconazole[1] D00351 [1] CYP17A1 💬[6] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬[1] 75
367NJ-Tube: Silicon ED Tube[1] Silicon---[1] 6
368NK Cells[1] Natural Killer Cell---[1] 26
369Nle4,D-Phe7]-a-melanocyte stimulating hormone or NDP-a-MSH----[1] 254
370Nle4-D-Phe7-alpha-MSH----[1] 254
371NLX-112----[1] 6
372NLY01----[1] 6
373NMDA[1] Ketamine[2] D00711 ,
D08098 		[5] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		[20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[1] 6
374NN 1841----[1] 288
375NN-220----[1] 78
376NN1841----[1] 288
377NN8630----[1] 78
378NN8640----[1] 78
379NNC 0109-0000-0012----[1] 46
380NNC 0141-0000-0100----[1] 46
381NNC 0142-0000-0002----[2] 46, 96
382NNC 0151-0000-0000----[2] 46, 49
383NNC 126-0083----[1] 78
384NNC 142-0002----[1] 46
385NNC0109-0012----[1] 46
386NNC0114-0000-0005----[1] 46
387NNC0114-0006----[3] 46, 49, 96
388NNC0142-0000-0002----[1] 96
389NNC0142-0002----[1] 46
390NNC0151-0000-0000----[1] 46
391NNC0195-0092----[1] 78
392NNC0195-0092 10 mg/1.5 ml PDS290-10----[1] 78
393NNC0195-0092 15 mg/1.5 ml PDS290-15----[1] 78
394NNC0195-0092 5 mg/1.5 ml PDS290-10----[1] 78
395NNC0195-0092 DP 6.7 mg ml 3 ml cartridge----[1] 78
396NNC0195-0092 PDS290 10 mg-1.5 ml----[1] 78
397NNC0195-0092 PDS290 10 mg/1.5 ml----[1] 78
398NNC0215-0384----[2] 46, 162
399NNC109-0012----[1] 46
400NNC126-0083[1] Somatropin pegol---[1] 78
401NNC142-0002----[1] 96
402NNC151-0000----[1] 46
403NNZ-2566----[2] 156, 206
404NNZ-2591[1] NNZ-2591---[1] 201
405NO----[12] 6, 13, 46, 58, 62, 86, 96, 97, 222, 226, 299, 321
406Nocturnal oxygen , nocturnal bi-level positive pressure ventilation[1] Oxygen[1] D00003 --[1] 299
407Nolpitantium Besylate----[1] 97
408NOMACOPAN[1] Nomacopan[1] D11473 [1] C5 💬[10] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 162
409Nomacopan (rVA576)[1] Nomacopan[1] D11473 [1] C5 💬[10] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 162
410Nomegestrol[1] Nomegestrol[1] D07222 [1] PGR 💬[5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 13
411Nomegestrol acetate[3] Acetate,
Nomegestrol,
Nomegestrol acetate		[2] D07222 ,
D08281 		[1] PGR 💬[5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 13
412Non applicabile----[4] 13, 49, 51, 256
413Non applicable----[2] 10, 19
414Non as of yet----[1] 97
415Non ATG Conditioning regimen----[1] 60
416NON COMMERCIAL----[1] 75
417Non disponibile----[1] 201
418Non invasive ventilation----[1] 299
419NON PROPIETRY, THEREFORE N/A----[1] 51
420Non-active stimulation----[1] 46
421Non-anti-TNF biologics----[2] 46, 271
422Non-biologic anti-rheumatic drugs----[1] 46
423Non-biologic Disease Modifying Anti-Rheumatic Drug (DMARD)----[1] 46
424Non-Biologic DMARDs----[3] 46, 86, 107
425Non-biological DMARD's----[1] 46
426Non-biological DMARDs----[1] 46
427Non-myeloablative Hematopoietic Stem Cell Transplantation----[1] 93
428Non-myeloablative high dose immunosuppressive therapy conditioning (HDIT)----[1] 49
429Non-nucleoside reverse transcriptase inhibitors----[1] 265
430Non-pegylated interferon----[1] 13
431Non-steroidal anti-inflammatory drug----[1] 46
432Non-steroidal anti-inflammatory drug (NSAID)----[1] 46
433Non-steroidal anti-inflammatory drugs----[1] 46
434Non-steroidal anti-inflammatory drugs (NSAIDs)----[1] 107
435Non-surgical periodontal therapy----[1] 46
436Nonbiologic DMARDs of investigator's choice----[1] 46
437None----[16] 6, 46, 51, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299
438None as of yet[1] Interleukin-1 alpha, human recombinant---[1] 46
439None assigned[1] Interleukin-1 alpha, human recombinant---[2] 231, 299
440None at this time[1] Interleukin-1 alpha, human recombinant---[2] 96, 140
441None given[1] Interleukin-1 alpha, human recombinant---[1] 97
442None yet[1] Interleukin-1 alpha, human recombinant---[1] 51
443Noninvasive ventilation----[1] 299
444Nonmyeloablative allogeneic hematopoietic stem cell transplantation----[6] 28, 51, 60, 62, 65, 285
445Norantipyrine----[1] 2
446NordiFlex----[1] 78
447Nordilet®----[1] 78
448Norditropin[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
449Norditropin 24 IU[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 195
450Norditropin FlexPro 10 mg[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
451Norditropin FlexPro 10 mg/1.5 ml[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
452Norditropin FlexPro 5 mg/1.5 mL[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
453Norditropin FlexPro 5mg/1.5 ml[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
454Norditropin Growth Hormone[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
455Norditropin NordiFlex®----[1] 78
456Norditropin NordiFlex® 10 mg/1.5 ml[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
457Norditropin NordiFlex® 10mg/1.5 ml[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
458Norditropin Simplex[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
459Norditropin SimpleXx----[5] 3, 78, 107, 193, 195
460Norditropin SimplexX (5mg/1,5 ml) (INN:somatropin)[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
461Norditropin SimpleXx (growth hormone)[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
462Norditropin SimpleXx 10 mg[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
463Norditropin SimpleXx 15 mg/1.5 ml[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 3
464Norditropin SimpleXx 5mg/1.5ml[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[2] 78, 107
465Norditropine simplex----[1] 238
466Norditropin®[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
467Norditropin® FlexPro®----[1] 78
468Norditropin® FlexPro® pen----[1] 78
469Norditropin® SimpleXx® 5 mg/1.5ml[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
470Norepinephrine[1] Norepinephrine[2] D00076 ,
D05206 		[9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		[14] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 22
471Norethindrone[1] Norethisterone[2] D00182 ,
D00953 		[1] PGR 💬[5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[4] 13, 46, 49, 299
472Norgestimate[1] Norgestimate[1] D05209 [1] PGR 💬[5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 299
473Normal human immunoglobulin G[1] Human immunoglobulin G---[1] 65
474Normal Saline----[18] 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 271, 276, 296, 299
475Normal Saline 0.9% Infusion Solution----[1] 22
476Normal Saline Enema----[1] 97
477Normal Saline for Injection----[1] 13
478Normal saline instillation----[1] 226
479Normal saline IV, salt tablets----[1] 299
480Normal saline solution[1] Sodium chloride[1] D02056 --[1] 299
481Normal saline:----[1] 299
482Normix----[1] 96
483NORMIX*AD 12CPR RIV 200MG----[1] 96
484Norovirus -specific T-cell (NST) therapy----[1] 65
485Norphenazone[1] Edaravone[1] D01552 --[1] 2
486Norspan----[1] 46
487Northera[1] Droxidopa[1] D01277 [9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		[14] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
488Nortriptyline[1] Nortriptyline[2] D00816 ,
D08288 		[2] SLC6A2,
SLC6A4 💬		[2] Serotonergic synapse, Synaptic vesicle cycle 💬[2] 6, 226
489Nortriptyline hydrochloride[1] Nortriptyline[2] D00816 ,
D08288 		[2] SLC6A2,
SLC6A4 💬		[2] Serotonergic synapse, Synaptic vesicle cycle 💬[1] 6
490Norucholic acid[1] norUrsodeoxycholic acid---[2] 93, 94
491Norucholic acid (NCA) 500 mg[1] norUrsodeoxycholic acid---[1] 93
492NorUDCA----[1] 94
493NorUDCA (Norursodeoxycholic acid)[1] norUrsodeoxycholic acid---[1] 94
494NorUrsodeoxycholic Acid[1] norUrsodeoxycholic acid---[1] 94
495Norursodeoxycholic acid, NCA[1] norUrsodeoxycholic acid---[1] 94
496Norvir[1] Ritonavir[1] D00427 --[2] 265, 299
497Norvir 100 mg film-coated tablets----[1] 299
498Novamin----[1] 299
499Novantrone[1] Mitoxantrone[2] D02166 ,
D08224 		[2] TOP2A,
TOP2B 💬		[1] Platinum drug resistance 💬[1] 13
500NOVANTRONE*INF 2MG/ML 5ML[1] Mitoxantrone[2] D02166 ,
D08224 		[2] TOP2A,
TOP2B 💬		[1] Platinum drug resistance 💬[1] 13
501Novartis Pharmaceuticals Corporation----[1] 13
502NOVATREX----[1] 13
503Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy----[1] 98
504Novo Rapid----[1] 299
505Novo Rapid Insulin (Novonordisk)----[1] 299
506Novolin-R insulin----[1] 127
507Novolog insulin----[1] 299
508NovoNorm 0.5 mg----[1] 299
509NovoNorm 1 mg----[1] 299
510NovoNorm 2 mg----[1] 299
511Novorapid / humalog short acting insulin----[1] 299
512NovoRapid 100 U/ml, solution for injection in a vial. NovoRapid Penfill 100 U/ml, solution for injection in a cartridge. NovoRapid FlexPen 100 U/ml, solution for injection in a pre-filled pen.----[1] 299
513NovoRapid Aspartate----[1] 299
514NOX-E36----[1] 49
515Noxafil[1] Posaconazole[1] D02555 --[3] 60, 65, 299
516NOXAFIL - 40 mg/ml oral suspension[1] Posaconazole[1] D02555 --[1] 299
517NOXAFIL - 40 MG/ML SOSPENSIONE ORALE USO ORALE FLACONE (VETRO) 105 ML 1 FLACONE[1] Posaconazole[1] D02555 --[1] 299
518NOXAFIL - oral suspension 40 mg/ml[1] Posaconazole[1] D02555 --[1] 299
519Noxafil 100 mg[1] Posaconazole[1] D02555 --[1] 299
520Noxafil 100 mg Tablets Gastro-Resistant[1] Posaconazole[1] D02555 --[1] 299
521Noxafil 40 mg/ml oral solution[1] Posaconazole[1] D02555 --[1] 65
522Noxafil Gastro resistant tablets[1] Posaconazole[1] D02555 --[1] 60
523Noxafil®[1] Posaconazole[1] D02555 --[2] 60, 299
524NP001----[1] 2
525NP031112----[1] 5
526NP031112 600mg----[1] 5
527NP031112 800mg----[1] 5
528NPB-01----[3] 13, 14, 162
529NPC transplantation----[1] 6
530NPC-02----[1] 171
531NPC-09----[1] 30
532NPC-12G gel----[2] 34, 158
533NPC-14----[1] 113
534NPI-001----[2] 90, 303
535NPL-2009----[1] 206
536NPLATE[1] Romiplostim[1] D08990 [1] MPL 💬[2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 63
537NPLATE 500 microgramos polvo para solución inyectable[1] Romiplostim[1] D08990 [1] MPL 💬[2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 63
538NPSP 558----[1] 235
539NPSP558----[1] 235
540NR----[1] 299
541NR082 injection----[1] 302
542NR2B NMDA Antagonist CP-101,606 (traxoprodil)[1] Ketamine[2] D00711 ,
D08098 		[5] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		[20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[1] 6
543NRTX-1001----[1] 141
544NS----[1] 2
545NS 2330----[1] 6
546NS-065/NCNP-01----[1] 113
547NS-089/NCNP-02----[1] 113
548NS-304----[3] 70, 86, 88
549NS-304 Placebo----[2] 70, 88
550NS2----[1] 160
551NS2330----[1] 6
552NSAIDs----[4] 46, 70, 107, 271
553NSAIDs (permitted,not necessary)----[1] 46
554NSAIDs and sulfasalazine[1] Sulfasalazine[1] D00448 --[1] 271
555NsNSAIDs----[2] 107, 271
556NSP001----[1] 96
557NT 101----[4] 5, 6, 7, 17
558NT-501----[2] 90, 303
559NT-I7[1] Efineptakin alfa[1] D11957 --[1] 25
560NT-KO-003----[1] 13
561NTBC----[1] 241
562NTCELL Implantation----[1] 6
563NTLA-2001----[1] 28
564NU100----[1] 13
565NUCALA[1] Mepolizumab[1] D04923 [1] IL5 💬[13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬[2] 44, 45
566Nucala 100 mg powder for solution for injection[1] Mepolizumab[1] D04923 [1] IL5 💬[13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬[2] 44, 45
567NuCel----[1] 70
568NucleomaxX----[1] 265
569Nucleoside analogue sparing HAART regimen----[1] 265
570Nucleoside reverse transcriptase inhibitors----[1] 265
571Nuedexta----[1] 2
572Null----[16] 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271
573Nulojix[1] Belatacept[1] D03222 [2] CD80,
CD86 💬		[12] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬[1] 46
574NurOwn (MSC-NTF cells)----[1] 13
575NurOwn® (MSC-NTF cells)----[1] 2
576Nursinersen----[1] 3
577NUSINERSEN[1] Nusinersen[1] D10881 [1] SMN2 💬-[1] 3
578Nusinersen Injectable Product[1] Nusinersen[1] D10881 [1] SMN2 💬-[1] 3
579NUSINERSEN SODIUM[1] Nusinersen[1] D10881 [1] SMN2 💬-[1] 3
580Nusinersen Treatments[1] Nusinersen[1] D10881 [1] SMN2 💬-[1] 3
581NuSpin----[1] 78
582Nutraceutical Combination----[1] 96
583Nutridrink-Impact----[1] 299
584Nutrition supplement----[1] 97
585Nutrition treat----[1] 96
586Nutritional dietary intervention----[2] 96, 97
587Nutritional Formulation Containing Exogenous Ketones----[1] 201
588Nutritional Supplement----[1] 90
589Nutritional supplementation standardized formula----[1] 78
590NUTROPIN[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
591Nutropin AQ----[4] 78, 134, 193, 299
592Nutropin AQ [somatropin (DNA origin) injection][1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 299
593NutropinAq----[1] 78
594NutropinAq 10 mg/2 ml[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
595NutropinAq 10 mg/2 ml (30 UI)[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
596NUTROPINAq 10 mg/2 ml (30 UI), solución inyectable[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
597NutropinAq 10mg/2ml (30 I.E.) Injektionsllösung[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 65
598NutropinAq 10mg/2ml solution for injection[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 96
599NutropinAq®[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 96
600Nuvion®----[1] 97
601NV1205----[1] 20
602NVF233----[1] 13
603NW-1015----[1] 6
604NW-1015E, EMD 1195686, MSC2191632B----[1] 6
605NX-13 250 mg----[1] 97
606NX-13 250mg IR----[1] 97
607NX-13 500mg IR----[1] 97
608NX-13 500mg MR----[1] 97
609NX1011----[1] 86
610NYX-458----[1] 6
611Nébivolol----[1] 113